“尝试权”立法：进步还是风险？ - Suppr

Suppr

超能文献

"Right-to-Try" Legislation: Progress or Peril?

作者信息

Yang Y Tony, Chen Brian, Bennett Charles

机构信息

George Mason University, Fairfax, VA

University of South Carolina, Columbia, SC.

出版信息

J Clin Oncol. 2015 Aug 20;33(24):2597-9. doi: 10.1200/JCO.2015.62.8057. Epub 2015 Jul 20.

DOI:10.1200/JCO.2015.62.8057

PMID:26195722

Abstract

摘要

相似文献

"Right-to-Try" Legislation: Progress or Peril?

J Clin Oncol. 2015 Aug 20;33(24):2597-9. doi: 10.1200/JCO.2015.62.8057. Epub 2015 Jul 20.

The Right to Try: An Overview of Efforts to Obtain Expedited Access to Unapproved Treatment for the Terminally Ill.

Food Drug Law J. 2015;70(4):617-41.

Minnesota's Right to Try law.

Minn Med. 2016 Jan-Feb;99(1):30-2.

Right-to-try laws: hope, hype, and unintended consequences.

Ann Intern Med. 2015 Nov 17;163(10):796-7. doi: 10.7326/M15-0148. Epub 2015 Sep 29.

The strange allure of state "right-to-try" laws.

JAMA Intern Med. 2014 Dec;174(12):1885-6. doi: 10.1001/jamainternmed.2014.5767.

[End-of-Life legislation modification expected on December].

Rev Infirm. 2014 Aug-Sep(203):6.

Principled compassion.

Nat Med. 2014 Dec;20(12):1355. doi: 10.1038/nm.3772.

Experts critical of America's right-to-try drug laws.

Lancet. 2015 Oct 3;386(10001):1325-6. doi: 10.1016/S0140-6736(15)00393-1.

Long-term care: end-of-life issues. End-of-year issue brief.

Issue Brief Health Policy Track Serv. 2008 Jan 7:1-23.

Long-term care: end-of-life issues. Issue brief.

Issue Brief Health Policy Track Serv. 2010 Jan 4:1-25.

引用本文的文献

Real-World Data and Evidence in Lung Cancer: A Review of Recent Developments.

Cancers (Basel). 2024 Apr 4;16(7):1414. doi: 10.3390/cancers16071414.

The Role of Physicians in Expanded Access to Investigational Drugs: A Mixed-Methods Study of Physicians' Views and Experiences in The Netherlands.

J Bioeth Inq. 2021 Jul;18(2):319-334. doi: 10.1007/s11673-021-10090-7. Epub 2021 Feb 15.

"I Think It's Been Met With a Shrug:" Oncologists' Views Toward and Experiences With Right-to-Try.

J Natl Cancer Inst. 2021 Jun 1;113(6):735-741. doi: 10.1093/jnci/djaa137.

The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials.

Contemp Clin Trials Commun. 2019 Aug 25;16:100443. doi: 10.1016/j.conctc.2019.100443. eCollection 2019 Dec.

Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the "Right to Try".

JACC Basic Transl Sci. 2018 May 30;3(2):280-293. doi: 10.1016/j.jacbts.2017.11.007. eCollection 2018 Apr.

Medical Negligence Determinations, the "Right to Try," and Expanded Access to Innovative Treatments.

J Bioeth Inq. 2017 Sep;14(3):385-400. doi: 10.1007/s11673-017-9791-z. Epub 2017 Jun 20.

Expanded Access of Investigational Drugs: The Experience of the Center of Drug Evaluation and Research Over a 10-Year Period.

Ther Innov Regul Sci. 2016 Nov;50(6):705-709. doi: 10.1177/2168479016656030.

An analysis of common ethical justifications for compassionate use programs for experimental drugs.

BMC Med Ethics. 2016 Oct 18;17(1):60. doi: 10.1186/s12910-016-0145-x.

Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.

BMC Med. 2016 Feb 2;14:17. doi: 10.1186/s12916-016-0568-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验